IKT

Inhibikase Therapeutics Inc (IKT) gets rating Initiated from Cantor Fitzgerald

Anna Perez

Inhibikase Therapeutics Inc’s recent filing unveils that its 10% Owner Sands Capital Life Sciences Pu acquired Company’s shares for reported ...

Analysts: IKT stock price target of 6.5 in 12 months

Jaxson Clark

The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or ...

The Potential Rise in the Price of Inhibikase Therapeutics Inc (IKT) following insiders activity

Daniel Torres

Inhibikase Therapeutics Inc’s recently made public that its 10% Owner Sands Capital Life Sciences Pu acquired Company’s shares for reported ...

Knox Daily
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.